$1,100,000 of CENCORA INC. lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Proposed modifications to the existing definition of distributor bona fide service fees The Equitable Community Access to Pharmacist Services Act (H.R. 1770/ S.2477) Inflation Reduction Act Extend payment increase under Medicare's physician fee schedule. Medicare Access & CHIP Reauthorization Act (MACRA). Physician Medicare reimbursement annual fee update. Pharmacy and Medically Underserved Areas Enhancement Act (S.1491). Seniors Access to Critical Medicines Act (H.R. 5526/S.3458). Protecting Patient Access to Cancer and Complex Therapies Act (S. 2764). Reimbursement policies impacting drug shortages Part B drug pricing changes Enhanced Oncology Model (EOM) Preventing and Mitigating Generic Drug Shortages Senate Finance Draft Medicare Drug Shortage Prevention Policies Pharmacy and Medically Underserved Area Enhancement Act (S.1491). Preventing and Mitigating Generic Drug Shortages The Equitable Community Access to Pharmacist Services Act (H.R. 1770/S.2477). Seniors Access to Critical Medications Act of 2023 (H.R. 5526/S.3458) House and Senate Agriculture, FDA and related agency Appropriation bills House and Senate Labor/HHS Appropriations bills Strategic National Stockpile. Essential Medicines Strategic Stockpile Act (H.R.405). Prescription Information Modernization Act (H.R.1503/S.2916). Drug Shortages Pandemic and All Hazards Preparedness Reauthorization and Response Act (legislation). Drug Supply Chain Security Act Implementation (DSCSA). Rolling Active Pharmaceutical Ingredient and Drug (RAPID) Reserve Act (S.2510/H.R.6802). SUPPORT Act Reauthorization (S.2433/H.R.4531). FY2025 National Defense Authorization Act. House E&C Drug Shortages Discussion Draft. FY 2024 Continuing Resolution. Seniors Access to Critical Medications Act of 2023 (H.R. 5526/S.3458) Department of Defense Essential Medicines Strategic Stockpile Amendment to NDAA Health Care Cybersecurity Improvement Act of 2024 (S.4054) Broadening Utilization of Proven and Effective Treatment for Recovery Act or the BUPE for Recovery Act (H.R.9886/S.5271) Tax Cuts and Jobs Act of 2017. LIFO accounting method"
You can find more data on corporate lobbying on Quiver Quantitative.
COR Insider Trading Activity
COR insiders have traded $COR stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $COR stock by insiders over the last 6 months:
- BOOTS ALLIANCE, INC. WALGREENS sold 4,438,171 shares for an estimated $1,067,646,415
- STEVEN H COLLIS (Executive Chairman) has made 0 purchases and 5 sales selling 125,281 shares for an estimated $30,234,679.
- SILVANA BATTAGLIA (Executive Vice President) has made 0 purchases and 2 sales selling 3,151 shares for an estimated $741,274.
- LAZARUS KRIKORIAN (SVP & Chief Accounting Officer) sold 1,816 shares for an estimated $454,753
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
COR Hedge Fund Activity
We have seen 567 institutional investors add shares of COR stock to their portfolio, and 469 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WALGREENS BOOTS ALLIANCE, INC. removed 4,438,171 shares (-18.2%) from their portfolio in Q3 2024, for an estimated $998,943,528
- PACER ADVISORS, INC. added 2,035,679 shares (+6855.3%) to their portfolio in Q3 2024, for an estimated $458,190,629
- BANK OF AMERICA CORP /DE/ removed 1,858,632 shares (-36.4%) from their portfolio in Q3 2024, for an estimated $418,340,890
- FMR LLC removed 1,089,917 shares (-21.0%) from their portfolio in Q3 2024, for an estimated $245,318,518
- VANGUARD GROUP INC added 1,076,944 shares (+5.3%) to their portfolio in Q3 2024, for an estimated $242,398,555
- JPMORGAN CHASE & CO removed 631,245 shares (-13.5%) from their portfolio in Q3 2024, for an estimated $142,080,624
- QUBE RESEARCH & TECHNOLOGIES LTD added 540,641 shares (+72.7%) to their portfolio in Q3 2024, for an estimated $121,687,476
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
